Roche Holdings AG on Monday shared results from the phase 3 persevERA Breast Cancer study of giredestrant combined with palbociclib in advanced cancer patients. Trial Misses Primary Goal The trial ...
Zacks Investment Research on MSN
Roche's giredestrant misses key goal in first-line breast cancer study
Roche RHHBY announced results from a late-stage study evaluating its investigational candidate, giredestrant, in combination ...
Old drugs, new ideas. That’s one of the core drivers of using artificial intelligence (AI) for drug development. Researchers using complex AI-fueled methods are now taking aim at what has become a ...
A younger person walks arm-in-arm with an older person at a care facility. (Geralt/Pixabay via Courthouse News) (CN) — Scientists at UC San Francisco and Gladstone Institutes have pinpointed two ...
The randomized, double-blind, placebo-controlled, multicenter study enrolled 992 patients globally. The intent-to-treat ...
A combination of two cancer drugs may provide a pathway to treat Alzheimer’s, according to a study published July 21 in Cell. Researchers from the University of California San Francisco developed and ...
Researchers are exploring cancer drugs as a potential treatment for Alzheimer's disease, a neurodegenerative disorder with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results